2-[5-chloro-2-(hydroxymethyl)phenyl]-1-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]ethanone
C20H21ClF3N3O2 — CID 158616581
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-chloro-2-(hydroxymethyl)phenyl]-1-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]ethanone
2-[5-chloro-2-(hydroxymethyl)phenyl]-1-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]ethanone (PubChem CID 158616581) has the molecular formula C20H21ClF3N3O2 and a molecular weight of 427.85 g/mol. Its IUPAC name is 2-[5-chloro-2-(hydroxymethyl)phenyl]-1-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]ethanone.
Molecular Properties
| Compound Name | 2-[5-chloro-2-(hydroxymethyl)phenyl]-1-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]ethanone |
|---|---|
| PubChem CID | 158616581 |
| Molecular Formula | C20H21ClF3N3O2 |
| Molecular Weight | 427.85 g/mol |
| Exact Mass | 427.13 |
| IUPAC Name | 2-[5-chloro-2-(hydroxymethyl)phenyl]-1-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]ethanone |
| SMILES | CC1CN(c2ncccc2C(F)(F)F)CCN1C(=O)Cc1cc(Cl)ccc1CO |
| InChI | InChI=1S/C20H21ClF3N3O2/c1-13-11-26(19-17(20(22,23)24)3-2-6-25-19)7-8-27(13)18(29)10-15-9-16(21)5-4-14(15)12-28/h2-6,9,13,28H,7-8,10-12H2,1H3 |
| InChIKey | QJCPYDHGLWFTHM-UHFFFAOYSA-N |
| XLogP | 3.53 |
| TPSA | 56.67 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.85 |
| LogP ≤ 5 | 3.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158616581 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.